Zapanta, Ana .
HRN: 25-24-34 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/24/2024
CEFUROXIME 1.5GM (VIAL)
06/24/2024
07/01/2024
IV
1.5 Grans
Q8
SP NSVD; PROM X 28H
Waiting Final Action
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes